WELLINGTON MANAGEMENT GROUP LLP
Position in KALV — KalVista Pharmaceuticals, Inc.
CIK 902219
Boston, MA
Position in KALV
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,159,182
+$182,763 QoQ
Shares Held
107,262
-12.4% QoQ
Ownership
0.201%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#62
of 182 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 70.5813801719155.ToString("F0")%
None 29.418619828084502.ToString("F0")%
Common Shares in KALV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026WELLINGTON MANAGEMENT GROUP LLP holds $14,418,547,095 across 180 Biotechnology names. KALV ranks #103 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,212,589 | $1,434,549,489 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,837,459 | $1,419,694,318 | |
| 3 | ARGX |
Argenx SE
|
1,021,457 | $745,918,971 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,935,925 | $640,539,501 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
6,027,819 | $586,205,394 | |
| 6 | CYTK |
Cytokinetics Inc
|
8,009,489 | $527,905,416 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
6,391,816 | $479,961,458 | |
| 8 | ASND |
Ascendis Pharma A/S
|
1,757,633 | $402,023,391 |
All Filings in KALV
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,159,182 | 107,262 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,976,419 | 122,379 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,535,312 | 126,052 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $1,502,433 | 132,900 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,457,132 | 126,268 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,040,648 | 122,863 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $1,365,548 | 117,923 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $989,790 | 84,023 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $941,268 | 79,365 | Shares | Defined | 2024-05-15 | |
| 2022-09-30 | $11,267,159 | 776,510 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,626,108 | 470,133 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $19,850,976 | 1,346,742 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $23,966,209 | 1,811,505 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $31,958,644 | 1,831,441 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $42,996,649 | 1,794,518 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $38,766,851 | 1,509,025 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $16,571,736 | 872,656 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $9,618,242 | 763,959 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $2,455,802 | 202,959 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,524,758 | 199,315 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||